Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
PACB
Valuace
70
Růst
15
Zdraví
75
Cena
$ 1.77
Dnes
--0.14 (-5.96%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.5B
Obrat
0B
Zisk
-1B
Aktiva
1B
Dluh
1B
ROE
0%
ROA
0%
PE
-1
PS
3
Cena 1R
1-3
⌀ Cena
1.52
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
07-04-2026
Poslední dividenda

Profil

Pacific Biosciences of California, Inc. navrhuje, vyvíjí a vyrábí sekvenční systémy pro řešení geneticky složitých problémů. Společnost poskytuje PacBio systémy, které provádějí, monitorují a analyzují biochemické sekvenční reakce; spotřební produkty, včetně jednomolekulových buněk v reálném čase (SMART); a různé reakční sady určené pro specifické pracovní postupy, jako je sada pro přípravu šablon pro konverzi DNA na dvouvláknové DNA formáty, včetně molekulárních biologických činidel, jako jsou ligáza, pufry a exonukleáza. Nabízí také vazebné sady, jako je modifikovaná DNA polymeráza používaná k navázání knihoven SMARTbell na polymerázu v přípravě na sekvenování; a sekvenční sady obsahují činidla potřebná pro on-instrumentální sekvenování v reálném čase, včetně fosholinkovaných nukleotidů. Společnost poskytuje služby výzkumným institucím, komerčním laboratořím, genomovým centrům, laboratořím veřejného zdravotnictví, nemocnicím a institucím klinického výzkumu, smluvním výzkumným organizacím a akademickým institucím, farmaceutickým společnostem a zemědělským společnostem. Své výrobky prodává prostřednictvím přímých prodejních sil v Severní Americe a Evropě, jakož i prostřednictvím distribučních partnerů v Asii, Evropě, na Blízkém východě, v Africe a Latinské Americe. Pacific Biosciences of California, Inc. má dohodu o rozvoji a komercializaci se společností Invitae Corporation. Společnost byla dříve známá jako Nanofluidics, Inc. a v roce 2005 se přejmenovala na Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. byla založena v roce 2000 a sídlí v Menlo Parku v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
575
Založení
2010-10-27
Adresa
1305 O’Brien Drive
CEO
Christian O. Henry

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues160.0160.0154.0200.5128.3130.578.990.978.693.590.792.860.628.226.033.91.7
Cost of Revenues114.9109.3116.7147.779.371.746.356.353.558.846.639.337.221.825.020.80.0
Gross Profit45.150.737.352.849.058.932.634.625.134.744.253.523.46.40.913.01.7
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues44.638.439.837.239.240.036.038.858.455.7
Cost of Revenues27.923.425.138.529.230.030.127.547.437.8
Gross Profit16.715.114.7-1.410.110.05.911.311.017.9
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0187.2193.0112.964.259.662.665.367.660.448.245.247.676.1111.8
Selling General & Admin Expenses0.00.00.0169.8160.9124.172.875.563.559.147.845.238.038.747.746.730.1
Depreciation & Amortization381.8504.953.426.57.60.12.11.07.28.43.93.74.25.66.65.85.2
Total Operating Expenses598.9608.2511.6387.2353.9237.0137.0135.1126.1124.4115.4105.686.384.095.3122.8141.9
Operating Income-553.8-557.6-474.3-334.5-304.8-178.2-104.4-100.5-101.0-89.8-71.2-29.1-62.9-77.5-94.3-109.8-140.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.044.547.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.046.043.4
Depreciation & Amortization0.04.44.6372.810.916.114.312.017.95.5
Total Operating Expenses57.953.959.5427.6163.174.1181.892.697.491.7
Operating Income-41.2-38.8-44.9-428.9-153.0-64.1-175.8-81.4-86.4-82.5
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.2
Interest Expense7.07.013.414.314.712.50.32.62.42.93.22.92.82.50.00.00.0
Other Expense7.711.5164.816.3-9.4-96.7133.816.40.80.50.123.4-0.50.7-0.10.4-0.1
IBT-546.1-546.1-309.5-318.2-314.2-274.929.4-84.1-102.6-92.2-74.4-31.7-66.2-79.3-94.5-109.4-140.2
Income Tax Expense0.30.30.3-11.4-17.3-93.6-7.0-6.30.8-5.03.3-0.42.43.20.0-0.4-0.2
Net Income-546.4-546.4-309.9-306.7-296.9-181.229.4-77.8-102.6-92.2-74.4-31.7-66.2-79.3-94.5-109.4-140.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.03.6
Interest Expense1.71.71.71.72.83.53.53.63.63.6
Other Expense1.01.23.02.6155.73.42.53.24.84.9
IBT-40.2-37.6-41.9-426.42.7-60.7-173.3-78.2-82.7-77.6
Income Tax Expense0.20.40.0-0.30.30.00.00.0-0.7-10.7
Net Income-40.4-38.0-41.9-426.12.4-60.7-173.3-78.2-82.0-66.9
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.21$-1.32$-0.89$0.18$-0.51$-0.76$-0.87$-0.83$-0.42$-0.94$-1.26$-1.69$-2.03$-14.10
EPS Diluted$0.00$0.00$0.00$-1.21$-1.32$-0.89$0.17$-0.51$-0.76$-0.87$-0.83$-0.42$-0.94$-1.26$-1.69$-2.03$-14.10
Shares Outstanding301.9300.0274.5253.6224.6204.1165.2152.5135.1105.789.175.670.562.855.753.99.9
Diluted Shares Outstanding301.9300.0288.4253.6224.6204.1175.0152.5135.1105.789.175.670.562.855.753.99.9
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.31$-0.26
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.31$-0.26
Shares Outstanding301.9300.8300.2296.9283.0272.9272.4269.6267.1255.0
Diluted Shares Outstanding301.9300.8300.2296.9306.9272.9272.4269.6267.1255.0
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents99.955.4179.9325.1460.7318.849.118.862.916.882.336.426.446.558.9147.7
Short Term Investments410.3334.6451.5447.2583.7237.219.583.546.455.248.664.986.254.0118.6136.0
Total Cash & ST Investments510.1389.9631.4772.31,044.4318.849.1102.462.972.082.3101.3112.5100.6177.4283.7
Accounts Receivable32.427.536.618.824.216.815.38.613.411.45.23.42.72.84.60.3
Inventory68.658.856.750.424.614.213.317.923.115.611.011.310.19.615.56.9
Other Current Assets17.019.517.310.312.54.93.42.80.90.50.71.71.12.02.12.2
Total Current Assets628.1495.7742.0855.01,105.7354.881.0131.7101.6109.0110.5117.8126.5115.0199.6293.1
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents56.554.858.555.478.099.576.6180.2-43.6209.3
Short Term Investments242.2259.9284.6334.6393.2410.3485.3451.5811.3620.6
Total Cash & ST Investments298.7314.7343.1389.9471.1509.8561.9631.7767.8829.9
Accounts Receivable30.632.331.627.529.432.430.336.630.524.0
Inventory53.253.854.058.865.768.667.356.768.367.6
Other Current Assets11.812.616.219.518.017.317.414.315.814.0
Total Current Assets394.2413.4444.9495.7584.2628.1677.0742.0884.7938.0
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment57.346.669.081.379.154.962.934.137.914.68.56.69.214.318.412.3
Goodwill369.1317.8462.3410.0410.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets443.3389.6457.0410.2411.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments1.90.012.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets9.810.83.710.51.24.44.04.54.514.312.00.20.50.40.30.3
Total Long-Term Assets881.4764.81,004.0912.1901.259.266.938.642.528.920.66.89.714.718.712.6
Total Assets1,509.51,260.41,746.01,767.12,007.0414.0148.0170.3144.1137.9131.1124.5136.2129.7218.3305.7
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment64.766.669.246.649.357.368.069.075.076.8
Goodwill317.8317.8317.8317.8369.1369.1462.3462.3463.8410.0
Intangible Assets16.117.218.2389.6436.4443.3450.1457.0461.8409.8
Long-Term Investments0.00.00.00.00.00.00.02.42.42.4
Other Long-Term Assets10.310.510.710.811.011.712.5-443.713.013.1
Total Long-Term Assets408.9412.1415.9764.8865.8881.4992.91,004.01,013.6909.7
Total Assets803.2825.5860.81,260.41,450.11,509.51,669.91,746.01,898.41,847.6
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable17.516.615.112.011.03.68.46.79.18.44.75.61.73.04.79.5
Short-Term Debt12.510.010.110.77.74.319.76.36.316.6-2.111.40.20.20.10.1
Other Current Liabilities29.225.853.521.928.618.3-13.90.80.61.71.61.59.88.27.98.0
Current Liabilities78.466.395.076.983.336.521.820.322.333.821.931.522.614.719.420.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable16.415.114.016.612.117.521.015.116.116.5
Short-Term Debt3.60.72.410.010.712.59.810.118.918.5
Other Current Liabilities43.229.134.925.820.029.224.869.9126.6211.4
Current Liabilities63.259.866.666.360.078.473.095.078.273.5
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt892.8662.4923.8946.6953.742.061.714.713.616.114.914.115.82.62.82.9
Capital Leases19.624.941.250.057.742.045.80.00.00.00.00.02.62.82.93.0
Def. Tax Liability19.60.00.00.0-25.0-2.30.00.00.00.4-0.80.9-2.40.00.00.0
Total Liabilities1,016.8753.91,044.71,204.21,216.078.593.156.258.053.257.669.667.020.326.925.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt699.5698.5696.7662.4910.1912.5921.6923.8926.1928.4
Capital Leases54.952.852.924.927.632.138.831.643.645.8
Def. Tax Liability0.00.00.00.00.00.00.041.2-5.1-5.0
Total Liabilities767.1764.0769.2753.9996.91,016.81,020.91,044.71,134.61,205.6
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.30.30.30.20.20.20.20.20.10.10.10.1684.5645.40.10.1
Retained Earnings-2,090.6-2,148.9-1,839.1-1,532.3-1,218.1-1,036.9-1,066.2-982.1-879.7-787.5-713.2-681.5-615.3-536.0-441.6-332.2
Comprehensive Income-0.50.40.2-4.8-1.10.10.00.00.00.00.00.00.00.00.10.0
Total Common Equity492.7506.6701.3562.9791.0335.554.9114.186.184.773.554.969.2109.4191.5279.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.30.30.30.30.30.30.30.30.30.3
Retained Earnings-2,654.9-2,616.9-2,575.0-2,148.9-2,151.3-2,090.6-1,917.3-1,839.1-1,757.1-1,690.2
Comprehensive Income0.40.30.40.41.6-0.5-0.30.2-1.8-2.7
Total Common Equity36.161.591.6506.6453.1492.7649.0701.3763.7642.0
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt925.0672.4933.9957.4953.742.061.714.713.616.114.914.116.02.82.93.0
Book Value492.7506.6701.3562.9791.0335.554.9114.186.184.773.554.969.2109.4191.5279.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value36.161.591.6506.6453.1492.7649.0701.3763.7642.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-400.4-546.4-309.9-306.7-314.2-181.229.4-84.1-102.6-92.2-74.4-31.7-66.2-79.3-94.5-109.4-140.2
Depreciation & Amortization49.60.053.326.517.311.69.39.97.28.43.93.74.25.66.65.85.2
Stock-Based Compensation73.00.00.072.178.673.417.516.423.220.419.613.89.99.99.712.49.7
Change Working Capital-52.04.4-40.6-59.0-54.021.0-2.8-3.05.7-6.0-18.0-31.4-0.833.71.0-12.02.9
Change In Accounts Receivable-8.4-7.99.1-17.85.5-7.2-1.6-6.74.8-2.0-6.2-1.7-0.70.11.7-4.2-0.3
Change In Accounts Payable1.42.51.40.21.014.9-0.81.7-2.20.83.4-0.73.9-1.3-1.8-4.83.6
Change In Inventories-10.9-1.4-8.3-13.8-33.9-12.4-1.13.93.6-8.4-6.2-2.5-1.3-0.14.8-11.4-6.9
Other Non-cash Items190.6430.791.219.39.157.7-33.9-16.81.01.31.0-2.31.30.20.30.20.4
Cash from Operations-252.70.00.0-259.2-263.2-111.219.5-78.3-66.4-67.5-67.9-47.9-51.5-29.8-76.8-103.0-122.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-40.4-38.0-41.9-426.12.4-60.7-173.3-78.2-82.0-66.9
Depreciation & Amortization0.04.44.6372.810.916.114.312.017.95.5
Stock-Based Compensation8.60.00.09.216.018.30.019.516.619.7
Change Working Capital7.53.2-3.9-2.48.4-17.3-6.3-25.3-7.7-12.6
Change In Accounts Receivable-4.81.6-0.6-4.11.93.1-2.16.3-6.1-6.5
Change In Accounts Payable1.71.31.0-1.53.6-5.6-3.36.6-1.5-0.4
Change In Inventories3.5-1.1-1.3-2.57.11.4-5.1-11.79.0-3.1
Other Non-cash Items5.211.711.83.0-68.2-1.8111.1-3.7-1.63.5
Cash from Operations0.00.00.00.00.00.00.00.0-57.6-65.2
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-8.2-2.7-6.2-8.8-16.9-5.9-1.0-2.8-1.9-10.4-8.2-3.0-1.6-0.9-1.7-9.3-5.3
Acquisitions-0.10.00.0-0.10.2-319.80.00.00.00.00.00.00.00.0-61.80.00.0
Investments-583.3-216.9-498.6-756.6-442.8-988.0-373.3-57.7-122.2-86.3-95.8-84.6-126.4-201.5-87.9-264.1-181.0
Sales of Investment810.0340.1628.8770.1575.8635.2155.0122.685.695.289.2100.7147.6169.3151.4279.848.0
Other Investing Activities148.40.00.00.0-0.20.00.00.00.00.00.0-4.50.00.061.80.00.0
Cash from Investing218.40.00.04.6116.1-678.5-219.362.0-38.4-1.5-14.98.619.6-33.161.86.4-138.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.90.1-0.6-1.4-1.60.8-1.5-3.9-2.0-0.8
Acquisitions0.00.00.00.00.00.00.00.00.0-0.1
Investments-33.1-65.8-56.2-61.8-80.5-114.6-111.7-191.9-202.8-76.9
Sales of Investment60.084.682.0113.4140.3136.9190.0161.7138.3320.1
Other Investing Activities0.00.00.00.00.00.00.00.0-64.6243.3
Cash from Investing0.00.00.00.00.00.00.00.0-66.6242.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-1.40.00.0-1.8-1.6-0.4-16.00.00.0-4.50.00.00.00.00.00.00.0
Debt Issued-11.3672.4-261.5-21.65.2912.1-3.747.01.02.01.20.8-1.813.2-0.1-0.13.0
Issuance of Common Stock15.00.00.0189.211.2294.8187.58.597.564.458.229.138.019.92.77.7210.8
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-80.00.00.0-78.50.0875.180.418.09.78.97.77.44.022.80.00.0107.9
Cash from Financing-75.90.00.0108.99.61,169.6251.826.5107.268.865.936.542.042.82.77.7318.7
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-0.4-0.5
Debt Issued703.13.90.126.7-248.3-4.2-6.4-2.6-1.2-1.6
Issuance of Common Stock0.00.00.00.00.00.00.00.00.94.6
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-82.1-0.3
Cash from Financing0.00.00.00.00.00.00.00.0-81.6-0.8
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-109.77.7-124.2-148.4-137.5379.952.010.32.3-0.3-16.9-2.810.1-20.2-12.3-88.858.4
Closing Cash Balance99.963.756.1179.9328.3465.885.933.623.316.516.833.636.426.446.558.9147.7
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash7.01.7-4.13.1-22.6-21.222.9-103.3-205.7176.4
Closing Cash Balance63.756.855.160.757.680.299.976.9180.2388.4
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-260.9-113.9-212.2-268.0-280.1-117.118.5-81.1-68.3-78.0-76.1-50.9-53.1-30.7-78.5-112.3-127.3
Real Free Cash Flow-334.0-113.9-212.2-340.1-358.8-190.50.9-97.5-91.4-98.3-95.7-64.7-63.0-40.6-88.2-124.6-136.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-24.9-18.6-29.9-50.4-32.3-44.7-55.7-79.6-59.6-66.0
Real Free Cash Flow-33.5-18.6-29.9-59.6-48.3-62.9-55.7-99.1-76.2-85.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1-8.1179.3
P/S3.527.9390.6
P/B15.46.8113.4
P/FCF-4.854.4149.9
Market cap$0.5$0.8
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %25.6 %0 %
Debt to Income-128.7 %-172.4 %0 %
Debt to Free cash flow-496.1 %-2285.4 %0 %
Interest expense percentage-1.3 %-3 %11.2 %
Current ratio6.2 7.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-1513.9 %-116 %0 %
ROA-68 %-41.2 %0 %
CapEx to Revenue1.2 %30 %6 %
RaD to Revenue0 %574 %0 %
ROEM278,269.6 126228

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin28.2 %36.5 %61.9 %
Operating margin-346.1 %-771.2 %17.9 %
Net margin-341.5 %-756.5 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding301.9 mil 140.7 mil
Employee count0.6 tis 0.5 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader